Bernard Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Bernard Wealth Management's PFE Position: Q2 2026 in Review
Bernard Wealth Management reduced its Pfizer (PFE) stake by 12% in Q2 2026, selling an estimated $2.96K and leaving 808 shares worth $19.5K. The position accounts for 0.01% of the portfolio, ranked #192.
Bernard Wealth Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $30.1K in Q4 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bernard Wealth Management held 808 shares of Pfizer worth $19.5K as of Q2 2026.
- Bernard Wealth Management sold 113 Pfizer shares in Q2 2026, an estimated $2.96K.
- Pfizer made up 0.01% of Bernard Wealth Management's portfolio in Q2 2026, its #192 holding.
- Bernard Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
- Bernard Wealth Management's Pfizer position peaked at $30.1K in Q4 2024.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bernard Wealth Management's 13F filing for Q2 2026, filed 21 Aug 2026.